Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease is a paper indexed in PICO Portal from OpenAlex.
How many citations does Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease have?
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease has 22 citations in the OpenAlex counts PICO Portal stores.
When was Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease published?
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease has 2012 year in the PICO Portal index.
What is the open-access status of Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease?
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease has bronze oa status in the PICO Portal index.
What is the DOI of Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease?
The DOI for Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease is on the source record.
What is the PMID of Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease?
The PMID for Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease is on the source record.
What is the OpenAlex record for Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease?
The OpenAlex for Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease is on the source record.